www.medical-devices.tech
09
'26
Written on Modified on
GE HealthCare Announces 510(k) Pending Status for StarGuide GX 4D SPECT/CT System
GE HealthCare has submitted the StarGuide GX 4D CZT SPECT/CT system for U.S. FDA 510(k) clearance, aiming to expand advanced molecular imaging and theranostics capabilities following its recent European CE Mark.
www.gehealthcare.com

The StarGuide GX digital 4D CZT SPECT/CT system provides clinicians with a versatile, general-purpose scanner designed to support modern nuclear medicine applications, including emerging radioligand therapies and investigational alpha emitters across broad energy spectrums.
Dual-Sided CZT Technology and Quantitative Precision
Traditional molecular imaging systems frequently force trade-offs between high spatial resolution and system sensitivity. StarGuide GX integrates GE HealthCare's patented dual-sided cadmium zinc telluride (CZT) detector technology to deliver double volume sensitivity while maintaining high-resolution output and precise quantitation. By combining dual-sided detector architecture with NVIDIA RTX computing, the system accelerates image reconstruction workflows and shortens scan durations. Furthermore, the patented dual-collimator mechanism executes automated collimator exchanges in under three seconds, removing the manual labor, storage footprint, and operational delays associated with multiple physical collimator carts.
Theranostics Integration and Emerging Tracer Support
The rapid expansion of theranostics relies on precise radioligand matching between diagnostic imaging and targeted cancer treatment. Investigative alpha-emitting isotopes, such as Actinium-225 and Lead-212, deliver short-range, high-energy radiation designed to target malignancies while preserving surrounding healthy tissue. StarGuide GX is engineered to image across diverse energy ranges, empowering nuclear medicine departments to evaluate treatment responses, execute complex dosimetry, and support clinical research pipelines for advanced theranostic applications.
Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement
The StarGuide GX 4D SPECT/CT platform builds upon advanced semiconductor detector configurations, shifting conventional scintillation crystal limitations toward direct conversion cadmium zinc telluride substrates. Competitive molecular imaging systems from manufacturers such as Siemens Healthineers and Philips Healthcare utilize varying solid-state or traditional Anger camera designs with digital photon counting or broad-spectrum multi-isotope capabilities. Quantitative benchmarks evaluating dual-sided CZT geometries demonstrate enhanced photopeak efficiency and spatial linearity improvements compared to single-sided semiconductor deployments, enabling superior contrast recovery coefficients for sub-centimeter lesion detection during high-throughput clinical protocols.
Edited by Sucithra Mani, Induportals editor – adapted by AI.
www.gehealthcare.com

